Jobs Career Advice Signup

Lekam International Pharmaceuticals Nigeria Ltd. Jobs in Nigeria

Latest Jobs Vacancies in Nigeria at Lekam International Pharmaceuticals Nigeria Ltd.

1 vacancy

About Lekam International Pharmaceuticals Nigeria Ltd.

PrzedsiÄ™biorstwo Farmaceutyczne LEK-AM Sp. o.o. is one of the most dynamically developing pharmaceutical companies on the Polish market. At present the company employs over 440 people and this number is gradually growing together with an expansion of individual company’s divisions.The production of company’s products is located in Zakroczym near Warsaw. Production is based in a modern pharmaceutical plant and a laboratory equipped with the highest quality devices. Production lines and laboratory operate according to European standards and a team of qualified and professional staff ensures the conformance with these standards. Methods of manufacturing meet all requirements of Good Manufacturing Practice (GMP) and products for clinical studies are manufactured in accordance with the guidelines of Good Laboratory Practice (GLP) and GMP. Today, in planning the production of new preparations, we gradually implement further stages of expansion the production base. Increasing production capacities goes together with consistent implementation of the newest technologies of drug production in order to ensure the highest quality of offered products.
  • Lekam International Pharmaceuticals Nigeria Ltd. Reviews

     
    No review available
    Do you currently work in this company or maybe have worked there before? Drop a review
  • Lekam International Pharmaceuticals Nigeria Ltd. Salaries

     
    Not available Anonymously drop your salary if you are working with this company or maybe have worked with them in the past.Drop your salary

Subscribe to Job Alert

 

Join our happy subscribers

This website uses cookies to improve your experience. By using this site you agree to the storing of cookies on your device to enhance navigation, analyze site usage, and assist in our marketing efforts. To learn more, see our Cookie Policy. Accept and Close